Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Drug Safety Newsletter 41st Edition

09 May 2011

Topics covered in this edition of the newsletter include:

  • Paracetamol - Available evidence does not support a causal relationship with asthma in children after exposure in pregnancy or use in early infancy
  • Provigil (Modafinil) – EU wide restriction of use and updated recommendations to support safer use
  • Tygacil (tigecycline) – recommendations for use
  • Efient (prasugrel) – reports of hypersensitivity reactions
  • Revlimid (lenalidomide) – risk of venous and arterial thromboembolic events
  • Direct Healthcare Professional Communications published on the IMB website since the last drug Safety Newsletter

Drug Safety Newsletter 41st Edition

Date Printed: 24 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971